
IPL 2025: You can be fit only by eating home-cooked food, says KKR's Ramandeep Singh
Kolkata: Kolkata Knight Riders batter Ramandeep Singh shared valuable insights into his fitness regimen, nutrition philosophy and daily routines that keep him at peak performance.
Growing up in Chandigarh with an international cyclist as a father gave Ramandeep a head start in understanding nutrition.
"Luckily, I have been blessed with a father who is an international cyclist. So, he has been teaching me a lot about diet from the beginning," Ramandeep revealed in KKR's fitness series 'Train Like a Knight'.
This early education emphasised the importance of non-vegetarian food and dairy products, which have remained staples in his diet.
The KKR batter revealed that he starts each day with traditional desi ghee, followed by a simple yet nutritious breakfast consisting of "2 whole eggs, 3 egg whites, whole wheat bread and curd".
This straightforward approach to nutrition underscores his belief that fitness doesn't require exotic ingredients or complicated meal plans.
Perhaps the most striking aspect of Ramandeep's nutrition philosophy is his unwavering commitment to home-cooked meals. "You can be fit only by eating home-cooked food. This is what I believe, that whatever you want to eat, cook it at home. You can't be fit by going to fancy restaurants," he emphasised.
He advocates for a simple approach to healthy eating that anyone can follow: "Sugar, fried food and flour. If you leave these three things, 90% of your food will take care of itself."
For those looking to begin their fitness journey, Ramandeep recommends bodyweight exercises like push-ups, squats, and pull-ups - the same exercises he started with as a youngster. "If we start early, there are a lot of benefits. When you are in a professional sport, you take very little time to become a professional athlete," he noted.
While many fitness enthusiasts focus solely on active training days, Ramandeep places equal importance on recovery. "The day we are not working out, we have a recovery day. So on that day, nutrition plays a significant role. The next day you are at 100%, you are peaking. So for that, I think the rest days are more important."
His pre-workout routine includes three grams of creatine, while post-workout nutrition focuses on protein with adequate fiber for proper absorption, which he gets from vegetables at dinner.
Throughout the interview, Ramandeep emphasised that fitness should be accessible to everyone. For those without gym access, he suggests simple alternatives: "You can do sprints because wherever there is space, you can do sprints. 20 meters is enough. Even if you're doing starts, that's really good."
He also shared his healthy alternative for satisfying sweet cravings - curd with jaggery and blueberries, which offers nutritional benefits while pleasing the palate.
The most important takeaway from Ramandeep's fitness philosophy is his emphasis on consistency and making healthy choices part of daily life. "In your day-to-day life, you brush your teeth every day. You bathe every day. So you should eat good food every day. You should train well."
The episode concluded with Ramandeep demonstrating a challenging single-leg squat exercise, inviting viewers to attempt the move and share their results with the hashtag #TrainLikeAKnight.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


India Gazette
4 hours ago
- India Gazette
"The wait was worth every second": Rinku Singh gets engaged to Samajwadi Party MP Priya Saroj in Lucknow
ANI 09 Jun 2025, 02:27 GMT+10 Lucknow (Uttar Pradesh) [India], June 9 (ANI): Indian cricketer Rinku Singh and Samajwadi Party MP Priya Saroj got engaged in a ceremony in Uttar Pradesh's Lucknow on Sunday. The southpaw posted on his official Instagram handle. 'This day has been in our hearts for so long - almost three years - and the wait was worth every second Engaged - with full hearts and a forever to go. ' Indian batter Rinku Singh and Samajwadi Party MP Priya Saroj held a grand engagement ceremony today, which had many political leaders and cricketers. Since the conclusion of the T20 World Cup, Rinku has become a regular in the format but has yet to earn a spot in the ODI format. Rinku has featured in two ODIs for India and holds pretty impressive List-A numbers. The southpaw has garnered 1,899 runs in 52 innings, averaging 48.69 while striking at 94.8. His excellent numbers include one hundred and 17 half-centuries. In 33 T201 matches and 24 innings, Rinku has scored 546 runs at an average of 42.00 and a strike rate of 161.06, with three half-centuries. He's yet to smash his maiden T201 century. The 27-year-old made his T201 debut against Ireland in 2023. Rinku has been one of the main players for Kolkata Knight Riders (KKR) in the Indian Premier League (IPL). He has played 59 matches in the T20 tournament and scored 1099 runs at a strike rate of 145.20. He slammed four half-centuries in the cash-rich tournament. (ANI)


Economic Times
5 hours ago
- Economic Times
KKR-backed IVI to buy ART Fertility Clinics for $450 million
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, according to people familiar with the matter. The acquisition marks a significant step in IVI RMA's global expansion, adding India to its presence in over 15 countries and more than 190 clinical offices across the US, Europe and Latin parties are in the final stages of documentation for a shareholders' agreement and are hoping to wrap up the transaction by June with private hospitals, the IVF industry in India too is witnessing consolidation as several private equity funds have been aggressive with acquisitions. In 2023, Swedish fund EQT Partners acquired a significant majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, at a $1.1 billion ('9,000 crore) Fertility Clinics began in 2015 as IVI Middle East, an international arm of IVI RMA Global. In 2020, IVI RMA divested the business to Gulf Capital, which rebranded it as ART Fertility Clinics. Since then, the brand has rapidly grown, expanding across West Asia and clinics in Abu Dhabi, Dubai and Al Ain in the UAE as well as 11 centres across India, ART Fertility has established itself as a high-performance network in reproductive medicine. The Indian expansion began in 2021, backed by a $30 million investment from Gulf Fertility operates in big Indian cities including Mumbai, Noida, Ahmedabad, Chennai, Hyderabad, Gurgaon and by Suresh Soni, former co-founder and CEO of Nova IVF Fertility, ART Fertility reports a pregnancy success rate of 70% and has recorded over 5,000 successful pregnancies in under nine to sources, ART Fertility posted revenue of $100-120 million in FY25, with an estimated Ebitda of $35 million."For an Indian healthcare player, a $25-35 million ebitda which is borderline ebitda positive coming from the Middle East would add no value," said a fund manager at a Mumbai-based private equity firm that operates a pan-India IVF chain. "However, IVI being a US player where multiples are low, adding a Middle East business works well."IVI RMA trumped a rival bid by Temasek-backed Cloudnine Hospitals.A KKR spokesperson declined to comment. IVI RMA and ART Fertility did not respond to is the advisor in the is rapidly emerging as one of the world's fastest-growing markets for Assisted Reproductive Technology (ART). However, the sector has scope for expansion at 210 IVF cycles per million people, compared with 1,200 in the US and over 2,000 in affects approximately 15% of Indian couples, a figure expected to rise due to lifestyle factors such as poor diet, stress, late marriages, and to EY, India's IVF market is expected to grow from $793 million in 2020 to $1.45 billion by 2027, at a projected CAGR of 15-20%.India sees around 300,000 IVF cycles annually, with projections suggesting this could grow to 500,000-600,000 cycles by 2030. About 30% of the market is controlled by 10-15 organised players, while the remaining is fragmented among smaller, unorganised clinics. Key players in India's fertility sector include Indira IVF, Nova IVF, Oasis IVF, Bloom Fertility Centre, Bengaluru-based Milann, Morpheus IVF, Ridge IVF, Akanksha IVF and Bourn Hall IVF, the second largest player in India, is owned by Asia Healthcare Holdings (AHH), the single specialty hospitals platform backed by GIC and homegrown PE fund Kedaara Capital owns a minority stake in Oasis Fertility, while Brussels-based fund Verlinvest owns a controlling stake in Ferty9 F, a premier chain of fertility clinics in the AP/Telangana region.


Time of India
6 hours ago
- Time of India
KKR-backed IVI to buy ART Fertility Clinics for $450 million
KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, according to people familiar with the matter. The acquisition marks a significant step in IVI RMA's global expansion, adding India to its presence in over 15 countries and more than 190 clinical offices across the US, Europe and Latin America. Both parties are in the final stages of documentation for a shareholders' agreement and are hoping to wrap up the transaction by June end. As with private hospitals, the IVF industry in India too is witnessing consolidation as several private equity funds have been aggressive with acquisitions. In 2023, Swedish fund EQT Partners acquired a significant majority stake in Indira IVF, the largest provider of fertility services in India and top five globally in terms of annual IVF cycles, at a $1.1 billion ('9,000 crore) valuation. ART Fertility Clinics began in 2015 as IVI Middle East, an international arm of IVI RMA Global. In 2020, IVI RMA divested the business to Gulf Capital, which rebranded it as ART Fertility Clinics. Since then, the brand has rapidly grown, expanding across West Asia and India. Live Events With clinics in Abu Dhabi, Dubai and Al Ain in the UAE as well as 11 centres across India, ART Fertility has established itself as a high-performance network in reproductive medicine. The Indian expansion began in 2021, backed by a $30 million investment from Gulf Capital. ART Fertility operates in big Indian cities including Mumbai, Noida, Ahmedabad, Chennai, Hyderabad, Gurgaon and Faridabad. Led by Suresh Soni, former co-founder and CEO of Nova IVF Fertility, ART Fertility reports a pregnancy success rate of 70% and has recorded over 5,000 successful pregnancies in under nine years. According to sources, ART Fertility posted revenue of $100-120 million in FY25, with an estimated Ebitda of $35 million. "For an Indian healthcare player, a $25-35 million ebitda which is borderline ebitda positive coming from the Middle East would add no value," said a fund manager at a Mumbai-based private equity firm that operates a pan-India IVF chain. "However, IVI being a US player where multiples are low, adding a Middle East business works well." IVI RMA trumped a rival bid by Temasek-backed Cloudnine Hospitals. A KKR spokesperson declined to comment. IVI RMA and ART Fertility did not respond to queries. Moelis is the advisor in the transaction. India is rapidly emerging as one of the world's fastest-growing markets for Assisted Reproductive Technology (ART). However, the sector has scope for expansion at 210 IVF cycles per million people, compared with 1,200 in the US and over 2,000 in Europe. Infertility affects approximately 15% of Indian couples, a figure expected to rise due to lifestyle factors such as poor diet, stress, late marriages, and pollution. According to EY, India's IVF market is expected to grow from $793 million in 2020 to $1.45 billion by 2027, at a projected CAGR of 15-20%. India sees around 300,000 IVF cycles annually, with projections suggesting this could grow to 500,000-600,000 cycles by 2030. About 30% of the market is controlled by 10-15 organised players, while the remaining is fragmented among smaller, unorganised clinics. Key players in India's fertility sector include Indira IVF, Nova IVF, Oasis IVF, Bloom Fertility Centre, Bengaluru-based Milann, Morpheus IVF, Ridge IVF, Akanksha IVF and Bourn Hall Clinic. Nova IVF, the second largest player in India, is owned by Asia Healthcare Holdings (AHH), the single specialty hospitals platform backed by GIC and TPG. Similarly, homegrown PE fund Kedaara Capital owns a minority stake in Oasis Fertility, while Brussels-based fund Verlinvest owns a controlling stake in Ferty9 F, a premier chain of fertility clinics in the AP/Telangana region.